Last: | $23.84 |
---|---|
Change Percent: | 0.29% |
Open: | $23.94 |
Close: | $23.84 |
High: | $24.02 |
Low: | $23.8 |
Volume: | 749,283 |
Last Trade Date Time: | 04/19/2024 03:00:00 am |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$23.84 | $23.94 | $23.84 | $24.02 | $23.8 | 749,283 | 04-19-2024 |
$24.01 | $23.9 | $24.01 | $24.205 | $23.85 | 1,443,351 | 04-18-2024 |
$23.92 | $24.04 | $23.92 | $24.05 | $23.83 | 1,065,889 | 04-17-2024 |
$23.8 | $23.8 | $23.8 | $23.99 | $23.65 | 976,530 | 04-16-2024 |
$23.8 | $23.99 | $23.8 | $24.08 | $23.72 | 916,744 | 04-15-2024 |
$23.77 | $24.19 | $23.77 | $24.19 | $23.66 | 1,068,235 | 04-12-2024 |
$24.52 | $24.59 | $24.52 | $24.64 | $24.36 | 562,794 | 04-11-2024 |
$24.35 | $24.41 | $24.35 | $24.5 | $24.235 | 482,988 | 04-10-2024 |
$24.66 | $24.54 | $24.66 | $24.715 | $24.53 | 540,132 | 04-09-2024 |
$24.35 | $24.47 | $24.35 | $24.53 | $24.315 | 852,377 | 04-08-2024 |
$24.47 | $24.3 | $24.47 | $24.55 | $24.29 | 493,336 | 04-05-2024 |
$24.34 | $24.58 | $24.34 | $24.605 | $24.22 | 644,009 | 04-04-2024 |
$24.61 | $24.51 | $24.61 | $24.73 | $24.4 | 804,537 | 04-03-2024 |
$24.27 | $24.5 | $24.27 | $24.74 | $24.17 | 1,366,574 | 04-02-2024 |
$24.54 | $24.85 | $24.54 | $24.86 | $24.19 | 1,401,657 | 04-01-2024 |
$25.36 | $25.65 | $25.36 | $25.85 | $25.32 | 3,057,363 | 03-29-2024 |
$24.898 | $25.1827 | $24.898 | $25.3791 | $24.8587 | 3,057,363 | 03-28-2024 |
$26.34 | $26.23 | $26.34 | $26.52 | $26.2 | 1,176,677 | 03-27-2024 |
$26.08 | $25.87 | $26.08 | $26.13 | $25.86 | 777,062 | 03-26-2024 |
$25.84 | $25.99 | $25.84 | $26.07 | $25.73 | 743,549 | 03-25-2024 |
News, Short Squeeze, Breakout and More Instantly...
Smith & Nephew SNATS Inc. Company Name:
SNN Stock Symbol:
NYSE Market:
Smith & Nephew SNATS Inc. Website:
Smith+Nephew (NYSE:SNN; LSE:SN), the global medical technology company is pleased to announce exciting data for its ALLEVYN LIFE Dressing in a recent study by Professor Amit Gefen and his research group published in the International Wound Journal , 1 that shows a novel mechanism of actio...
Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, today announces the review of medical technologies guidance from the UK National Institute for Health and Care Excellence (NICE) for its PICO Single Use Negative Pressure Wound Therapy System (sNPWT). NICE have rev...
Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, is pleased to announce the launch of its RENASYS EDGE Negative Pressure Wound Therapy (NPWT) System in the US as a patient-centric option for treating chronic wounds. The system is lightweight and compact allowing i...